Researchers from the Californian university in Davis have developed a technique, which can modify genes of cytomegalovirus by inserting DNA fragments of other viruses. They gave samples of modified virus to Oregon, where he created a vaccine for monkeys. About 60 percent of this vaccine vaccinated macaques were resistant to infection with SIV. Now representatives of the University of Oregon are looking for volunteers willing to participate in clinical trials a “human” version of the drug.
Cytomegalovirus belongs to the group of herpes viruses. He often amazes the people, and, although infected more among the elderly and representatives of disadvantaged communities, infected discover among all social classes. More than half of the US population carry CMV. It may not manifest itself for years, however, sometimes causes a disease called cytomegalovirus. Transmission of cytomegalovirus from person to person is difficult, but possible.